Expression and significance of pituitary tumor-transforming gene 1 in patients with hepatocellular carcinoma

doi:10.3877/cma.j.issn.2095-3232.2018.05.018

Abstract

Abstract:

Objective

To investigate the expression and significance of pituitary tumor-transforming gene (PTTG) 1 in the liver tissues of patients with hepatocellular carcinoma (HCC).

Methods

60 HCC pathological tissues of patients undergoing hepatectomy from July 2011 to December 2016 and 15 fresh HCC and para-cancerous tissues of patients undergoing hepatectomy from June to December 2016 in the Third Affiliated Hospital of Sun Yat-sen University were collected. The informed consents of all patients were obtained and the local ethical committee approval was received. Normal liver tissues distant from the hemangioma of 24 patients undergoing lobectomy were collected as normal controls. The expression level of PTTG1 in HCC tissues was detected by immunohistochemistry, Western blot and RT-PCR. The correlation between expression levels of PTTG1 and clinical parameters of patients were analyzed using t test, Mann-Whitney test and Kruskal-Wallis test. The rate comparison was conducted by Chi-square test or Fisher's exact test.

Results

Immunohistochemical staining demonstrated that the positive rate of PTTG1 in HCC tissues and para-cancerous tissues were 65% (5%, 80%) and 3% (2%, 6%), significantly higher than 2% (1%, 2%) in normal control tissues (Z=6.644, 3.876; P<0.05). Western blot revealed that the relative expression levels of PTTG1 in HCC tissues and para-cancerous tissues were 0.88 (0.80, 1.78) and 0.83 (0.53, 1.27), significantly higher than 0.36 (0.20, 0.62) in normal control tissues (Z=3.223, 2.605; P<0.05). RT-PCR showed that the relative expression of PTTG1 mRNA in HCC tissues was 3.09 (1.46, 4.77), significantly higher than 0.90 (0.62, 1.14) in para-cancerous tissues (Z=2.605, P<0.05). In HCC tissues, the expression of PTTG1 protein was correlated with the degree of differentiation (χ2=3.849, P<0.05). The PTTG1 expression in para-cancerous tissues was correlated with age, serum level of α-L-fucosidase and tumor size (t=2.463, χ2=4.342, 6.070; P<0.05).

Conclusions

PTTG1 is highly expressed in HCC tissues. The expression of PTTG1 protein is correlated with the serum level of α-L-fucosidase, tumor size and degree of differentiation in HCC patients.

Key words: Pituitary tumor-transforming gene 1, Carcinoma, hepatocellular, alpha-L-fucosidase

Jieying Xuan, Yunwei Guo, Haoxiong Zhou. Expression and significance of pituitary tumor-transforming gene 1 in patients with hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(05): 426-430.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3232.2018.05.018

https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/Y2018/V07/I05/426

Figures/Tables 3

References 20

[1]	Pei L. Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function[J]. J Biol Chem, 2000, 275(40):31191-31198.
[2]	Solbach C, Roller M, Fellbaum C, et al. PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence[J]. Breast, 2004, 13(1):80-81.
[3]	Romero F, Multon MC, Ramos-Morales F, et al. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase[J]. Nucleic Acids Res, 2001, 29(6):1300-1307.
[4]	Boelaert K, McCabe CJ, Tannahill LA, et al. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer[J]. J Clin Endocrinol Metab, 2003, 88(5): 2341-2347.
[5]	Fromowitz FB, Viola MV, Chao S, et al. ras p21 expression in the progression of breast cancer[J]. Hum Pathol, 1987, 18(12):1268-1275.
[6]	Bradshaw C, Kakar SS. Pituitary tumor transforming gene: an important gene in normal cellular functions and tumorigenesis[J]. Histol Histopathol, 2007, 22(2):219-226.
[7]	Haji Amousha MR, Sabetkish N, Heshmat R, et al. Expression of the pituitary tumor transforming gene (PTTG1) in pheochromocytoma as a potential marker for distinguishing benign versus malignant tumors[J]. Acta Med Iran, 2015, 53(4):236-241.
[8]	Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification[J]. Semin Liver Dis, 1999, 19(3): 329-338.
[9]	中华人民共和国卫生和计划生育委员会医政医管局．原发性肝癌诊疗规范(2017年版)[J]．中华消化外科杂志，2017，16(7):635-647.
[10]	Cao XL, Gao JP, Wang W, et al. Expression of pituitary tumor transforming gene 1 is an independent factor of poor prognosis in localized or locally advanced prostate cancer cases receiving hormone therapy[J]. Asian Pac J Cancer Prev, 2012, 13(7):3083-3088.
[11]	Cho-Rok J, Yoo J, Jang YJ, et al. Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo[J]. Hepatology, 2006, 43(5):1042-1052.
[12]	Liang M, Chen X, Liu W, et al. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma[J]. Cancer Biol Ther, 2011, 11(3): 337-345.
[13]	金中元，程瑞雪，郑长黎，等．PTTG基因表达在原发性肝细胞癌发生中的作用及其机制的初步研究[J]．中国现代医学杂志，2004，14(24):37-40, 47.
[14]	Prezant TR, Kadioglu P, Melmed S. An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family[J]. J Clin Endocrinol Metab, 1999, 84(3):1149-1152.
[15]	Zhang X, Horwitz GA, Prezant TR, et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG)[J]. Mol Endocrinol, 1999, 13(1):156-166.
[16]	Domínguez A, Ramos-Morales F, Romero F, et al. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. evidence for a transcriptional activation function of hPTTG[J]. Oncogene, 1998, 17(17):2187-2193.
[17]	Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors[J]. Gastroenterology, 2004, 127(5 Suppl 1):S35-50.
[18]	MacDonald DC, Nelson M, Bower M, et al. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era[J]. World J Gastroenterol, 2008, 14(11):1657-1663.
[19]	Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG)[J]. Mol Endocrinol, 1997, 11(4):433-441.
[20]	Deugnier Y, David V, Brissot P, et al. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?[J]. Hepatology, 1984, 4(5):889-892.

参数		癌旁组织PTTG1阳性率		统计值	P值
参数		<5%（33例）	≥5%（22例）	统计值	P值
性别（例）		?	?	χ²=1.146	0.284
?	男	29	16	?	?
?	女	4	6	?	?
年龄（岁，±s）		47±10	54±10	t=-2.463	0.017
肝硬化（例）		?	?	χ²=1.115	0.291
?	无	9	9	?	?
?	有	24	13	?	?
Child-Pugh分级（例）		?	?	-	1.000
?	A级	32	21	?	?
?	B级	1	1	?	?
α-L-岩藻糖苷酶（例）		?	?	χ²=4.342	0.037
?	≤40 U/L	15	4	?	?
?	> 40 U/L	18	18	?	?
HBV-DNA（例）		?	?	χ²=0.315	0.575
?	≤10⁴ IU/ml	17	12	?	?
?	> 10⁴ IU/ml	16	10	?	?
AFP（例）		?	?	χ²=1.856	0.173
?	≤400 μg/L	24	12	?	?
?	> 400 μg/L	9	10	?	?
肿瘤直径（例）		?	?	χ²=6.070	0.014
?	≤3 cm	15	3	?	?
?	> 3 cm	18	19	?	?
分化程度（例）		?	?	χ²=1.360	0.244
?	高、高中、中分化	27	15	?	?
?	中低、低分化	6	7	?	?
TNM分期（例）		?	?	χ²=0.783	0.376
?	Ⅰ、Ⅱ	26	15	?	?
?	Ⅲa～Ⅳb	7	7	?	?
BCLC分期（例）		?	?	χ²=0.940	0.332
?	A、B期	25	14	?	?
?	C、D期	8	8	?	?
国内临床分期（例）		?	?	χ²=1.115	0.291
?	Ⅰa、Ⅰb	24	13	?	?
?	Ⅱa～Ⅲb	9	9	?	?

参数		癌旁组织PTTG1阳性率		统计值	P值
参数		<5%（33例）	≥5%（22例）	统计值	P值
性别（例）		?	?	χ²=1.146	0.284
?	男	29	16	?	?
?	女	4	6	?	?
年龄（岁，±s）		47±10	54±10	t=-2.463	0.017
肝硬化（例）		?	?	χ²=1.115	0.291
?	无	9	9	?	?
?	有	24	13	?	?
Child-Pugh分级（例）		?	?	-	1.000
?	A级	32	21	?	?
?	B级	1	1	?	?
α-L-岩藻糖苷酶（例）		?	?	χ²=4.342	0.037
?	≤40 U/L	15	4	?	?
?	> 40 U/L	18	18	?	?
HBV-DNA（例）		?	?	χ²=0.315	0.575
?	≤10⁴ IU/ml	17	12	?	?
?	> 10⁴ IU/ml	16	10	?	?
AFP（例）		?	?	χ²=1.856	0.173
?	≤400 μg/L	24	12	?	?
?	> 400 μg/L	9	10	?	?
肿瘤直径（例）		?	?	χ²=6.070	0.014
?	≤3 cm	15	3	?	?
?	> 3 cm	18	19	?	?
分化程度（例）		?	?	χ²=1.360	0.244
?	高、高中、中分化	27	15	?	?
?	中低、低分化	6	7	?	?
TNM分期（例）		?	?	χ²=0.783	0.376
?	Ⅰ、Ⅱ	26	15	?	?
?	Ⅲa～Ⅳb	7	7	?	?
BCLC分期（例）		?	?	χ²=0.940	0.332
?	A、B期	25	14	?	?
?	C、D期	8	8	?	?
国内临床分期（例）		?	?	χ²=1.115	0.291
?	Ⅰa、Ⅰb	24	13	?	?
?	Ⅱa～Ⅲb	9	9	?	?

Please choose a citation manager

Content to export